Genetic Technologies

About:

Genetic Technologies is a molecular diagnostics company specializing in oncology.

Website: http://www.gtgcorporate.com

Top Investors: Kentgrove Capital

Description:

Genetic Technologies is a global molecular diagnostic business with an extensive range of international patents and a portfolio of tests and related services. Our aim is simple: to concentrate on markets where we can establish a long-term dominant position by providing tests that genuinely affect clinical outcomes. We are already the leading non-government genetic testing business in Australia, and through our wholly owned subsidiary Phenogen Sciences, we now have a solid and growing presence in the USA. We remain committed to the development of a global portfolio of cancer management tests. The first of which is the Breast Cancer Risk Assessment Test, BREVAGenTM.

Total Funding Amount:

$38.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Fitzroy, Victoria, Australia

Founded Date:

1987-01-01

Contact Email:

info(AT)gtglabs.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2024-04-19

IPO Status:

Public

Industries:

© 2025 bioDAO.ai